Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

Epsilogen, a global leader in the development of immunoglobulin E antibodies to treat cancer, announces the appointments of Ashley Nagle as Chief Business Officer and Peter Finan, currently a Non-Executive Director, as Non-Executive Chairman.